Dr. Reddy's Q4 & FY23 Financial Results : vimarsana.com

Dr. Reddy’s Laboratories Ltd. today announced its consolidated financial results for the fourth quarter and full year ended March 31, 2023. The information mentioned in this release is on the... | May 10, 2023

Related Keywords

United Kingdom , India , United States , Hong Kong , Romania , Singapore , Russia , America , , Exchange Commission , Nimbus Health Gmb , Drug Administration , Indivior Inc , International Toll Free Number , Aquestive Therapeutics Inc , Reddy Laboratories , International Financial Reporting Standards , Reddy Laboratories Ltd , Indivior United Kingdom , Business Wire , Laboratories Limited , Earnings Per Share , Active Ingredients , North America , Emerging Markets , North America Generics , Lurasidone Tablets , Lubiprostone Capsules , Sunitinib Capsules , Nelarabine Injection , Abbreviated New Drug Applications , Statement Highlights , Nimbus Health Gmbh , Indivior United Kingdom Limited , Aquestive Therapeutics , Ended March , Investment Income , Before Interest , Capital Employed , Call Details , Express Join , Access Number , Toll Free Number , Playback Code , Annual Report , Dr Reddys Laboratories Limited Stock Exchange , News , Information , Press Release , Laboratories , Oday , Nnounced , Its , Onsolidated , Financial , Results , Or , The , Fourth , Quarter , End , Bull , Ear , Nded , Arch , Mentioned , N , This , Release , Us , N 500124 Ine089a01023 ,